| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/171.6.1481 |
| P698 | PubMed publication ID | 7769282 |
| P50 | author | Jukka Finne | Q20249488 |
| Genevieve Rougon | Q59553924 | ||
| P2093 | author name string | N Hanai | |
| R Gerardy-Schahn | |||
| H V Raff | |||
| H Jennings | |||
| J Häyrinen | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1481-1490 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides | |
| P478 | volume | 171 |
| Q63253490 | A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide |
| Q38200261 | A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty |
| Q35689237 | Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis. |
| Q90366018 | An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis |
| Q47916529 | Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? |
| Q34033132 | Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B. |
| Q36242262 | Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? |
| Q43992230 | Assessment of vaccine potential of the Neisseria-specific protein NMB0938. |
| Q40235865 | BMP signaling regulates murine enteric nervous system precursor migration, neurite fasciculation, and patterning via altered Ncam1 polysialic acid addition |
| Q41810415 | Binding of the receptor tyrosine kinase TrkB to the neural cell adhesion molecule (NCAM) regulates phosphorylation of NCAM and NCAM-dependent neurite outgrowth |
| Q35123584 | Bioorthogonal chemical reporter methodology for visualization, isolation and analysis of glycoconjugates |
| Q84554545 | Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease |
| Q71914698 | Can malignancy in insulinoma be predicted by the expression patterns of beta 1,6 branching of asparagine-linked oligosaccharides and polysialic acid of the neural cell adhesion molecule? |
| Q30164390 | Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies |
| Q34189137 | Conjugates and reverse vaccinology to eliminate bacterial meningitis |
| Q34002334 | Differences in surface expression of NspA among Neisseria meningitidis group B strains. |
| Q34076321 | Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group B |
| Q36257680 | Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration |
| Q44203036 | High affinity binding of long-chain polysialic acid to antibody, and modulation by divalent cations and polyamines. |
| Q37646974 | Immunization update II. |
| Q35783578 | Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay |
| Q40625765 | Lec3 Chinese Hamster Ovary Mutants Lack UDP-N-acetylglucosamine 2-Epimerase Activity Because of Mutations in the Epimerase Domain of the Gne Gene |
| Q37099232 | Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2 |
| Q38011312 | Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease |
| Q38452524 | Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications |
| Q36964235 | Metabolic glycoengineering of mesenchymal stromal cells with N-propanoylmannosamine |
| Q37405391 | Metabolic glycoengineering: sialic acid and beyond |
| Q38360730 | Mutant bacteriophage with non-catalytic endosialidase binds to both bacterial and eukaryotic polysialic acid and can be used as probe for its detection |
| Q28378942 | N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis |
| Q24675323 | NadA, a novel vaccine candidate of Neisseria meningitidis |
| Q33975380 | Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). |
| Q77566070 | Polysialic acid: three-dimensional structure, biosynthesis and function |
| Q35544310 | Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys |
| Q36009616 | Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease |
| Q34185172 | Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains |
| Q43455107 | Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level |
| Q27677157 | Structure ofNeisseria meningitidislipoprotein GNA1162 |
| Q34270429 | The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein |
| Q77458322 | The polysialic acid units of the neural cell adhesion molecule N-CAM form filament bundle networks |
| Q33792844 | The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies |
| Q36370598 | Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 |
| Q37115883 | Vaccine potential of the Neisseria meningitidis 2086 lipoprotein |
| Q92426572 | [From a pathogen's genome to an effective vaccine: the four-component meningococcal serogroup B vaccine] |
Search more.